Results 221 to 230 of about 11,744,847 (379)
A fixed point theorem of the alternative, for contractions on a generalized complete metric space [PDF]
J. B. Díaz, Beatriz Margolis
openalex +1 more source
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source
Fixed point theorems for point-to-set mappings and the set of fixed points [PDF]
openaire +3 more sources
From Moral Fixed Points to Epistemic Fixed Points
In a recent paper Terence Cuneo and Russ Shafer-Landau argue that there are moral conceptual truths that are substantive in content, what they called “moral fixed points.” I argue that insofar as we have some reason to postulate moral fixed points, we have equal reason to postulate epistemic fixed points (e.g. the factivity condition).
openaire +3 more sources
Hardware Implementation of a Fixed-Point Decoder for Low-Density Lattice Codes. [PDF]
Srivastava R, Gaudet VC, Mitran P.
europepmc +1 more source
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source
Research on Subpixel Algorithm of Fixed-Point Tool Path Measurement. [PDF]
Zhang X, Guo Z, Liu X, Zhang L.
europepmc +1 more source
FIXED-POINT THEOREMS FOR NONCOMPACT MAPPINGS IN HILBERT SPACE [PDF]
Felix E. Browder
openalex +1 more source
Clinical significance of stratifying prostate cancer patients through specific circulating genes
We tested a specific panel of genes representative of luminal, neuroendocrine and stem‐like cells in the blood of prostate cancer patients, showing predictive value from diagnosis to late stages of disease. This approach allows monitoring of treatment responses and outcomes at specific time points in trajectories.
Seta Derderian+12 more
wiley +1 more source